Medico Remedies — 360° view

Medico Remedies, a company in the Pharmaceuticals industry, reported revenue of ₹74 crore and net profit of ₹2.38 crore for the September 2026 quarter.

Medico Remedies (NSE: MEDICO) closed at ₹18.54 on 20 Nov 2026, down 63.4% over the past year. Its market capitalisation is ₹154 crore and it trades at 11.3 times earnings.

Share price
₹18.54 (20 Nov 2026)
Market cap
₹154 Cr (20 Nov 2026)
P/E
11.29 (20 Nov 2026)
Revenue
₹74 Cr (September 2026 quarter)
Net profit
₹2 Cr (September 2026 quarter)
ROCE
23.3% (FY26)
ROE
19.0% (FY26)
Book value
₹9.68 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹56.88 / ₹17.81 (20 Nov 2026)
1-year return
-63.4% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: MEDICO

Incorporated in 1994, Medico Remedies Ltd manufactures and sells pharmaceutical formulations

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.